Digital Health

Cybersecurity
- Uncategorized
Digital patient management
Digital policy & regulation
Healthcare Innovation
ICT and Health
Tech & Pharma
Tech companies & Data

Text search

Sort by Name

Click to order products ascending

Display 15 Products per page

Telehealth, Wearables and Apps – Report 1

$400.00

> Engaging Patients and Navigating Laws: What To Consider When Developing Health Apps
> Telehealth Reforms Praised At Senate Hearing
> Philips’ Survey Highlights Gaps In Perceptions Of Health Care
> Game On For Akili’s Cognitive Control Tech
December 1, 2017
Find out more
Telehealth, Wearables and Apps – Report 2

$400.00

> Behind The Scenes Of Digital Health: Medtech Players And Partners
> Philips To Create More Context, Connectedness And Continuity And Shift Sick Care To Health Care
> New Data Gives Adherium Fuel To Accelerate Digital Tech Adoption in Drug Sector
> Siemens Healthineers To Launch Digital ‘One-Stop-Shop’
December 1, 2017
Find out more
Telehealth, Wearables and Apps – Report 3

$300.00

> Reckitt Reaps ROI Reward In Geo-Targeted Symptoms App Promoting Mucinex, Delsym
> Biogen CMO Notes iPhone’s Potential For Early Detection of Alzheimer’s
> Interview: Philips Plugs Into Patient Connectivity
December 1, 2017
Find out more
The Intersection Between Tech and Pharma Special Report (Part 2. Apple)

$3,000.00

In January 2015, Fortune reported that at $2.9tn, the state of the US healthcare industry is very strong and continues to grow. Additionally, a Top Issues report revealed that 40% of Fortune 50 companies pursued new healthcare partnerships in 2014. Given the rapid change in the healthcare industry over the last few years, it is no surprise that we are starting to see more non-traditional healthcare partnerships, specifically with big tech companies.
January 14, 2016
Find out more
The Intersection Between Tech and Pharma Special Report (Part 3. Intel, Samsung, IBM, and GE)

$3,000.00

The Intersection Between Tech and Pharma Special Report (Part 3. Intel, Samsung, IBM, and GE)
January 22, 2016
Find out more
Transforming Pharmaceutical R&D with Data

$2,995.00

Ongoing pressures on drug pricing and reimbursement mean that current research and development (R&D) economics are unsustainable. The process of discovering and developing a drug has not fundamentally changed for decades, and on average it still costs $2.6bn and takes over 10 years. Fortunately, tools are emerging to help improve R&D success rates. Most are built on better use of more kinds of data, including using artificial intelligence (AI) to process massive quantities of information that humans cannot manage. Some of these new tools promise cost and time savings of between 20–50%
May 2, 2017
Find out more
US Zantac Sales And Distribution Continue As Sanofi Tests For NDMA

$200.00

Sanofi plans to continue distributing Zantac OTC heartburn remedy in the US while conducting its own tests to determine whether levels of N-nitrosodimethylamine (NDMA) in the active ingredient are above safe levels, Novartis AG, which licenses OTC Zantac, has said it stopped distribution worldwide.
August 2, 2019
Find out more
Virtual AI Nurses And The Future Of Chronic Disease Management

$200.00

What’s in store for chronic disease management in the future? Tap into this informal discussion with health entrepreneur Julia Hu, founder of Lark Health, for a look at her views of what’s to come, including the use of artificial intelligence nursing.
March 6, 2019
Find out more
Wearables are Transforming R&D and Care Delivery

$2,995.00

Wearable technologies have the potential to transform medicine and the delivery of healthcare more significantly than any other component of the digital revolution – or indeed than many other scientific advances.
June 6, 2016
Find out more

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Call Back

Name

Email *

Company name *

Phone number *